Nonsurgical Management of Cartilage Defects of the Knee: Who, When, Why, and How?

被引:3
|
作者
Hanaoka, Chad [1 ]
Fausett, Cameron [1 ,2 ]
Jayabalan, Prakash [1 ,3 ]
机构
[1] Shirley Ryan AbilityLab, Dept Phys Med & Rehabil, 355 E Erie St, Chicago, IL 60611 USA
[2] Northwestern Univ, Mcgaw Med Ctr, Dept Phys Med & Rehabil, Chicago, IL 60611 USA
[3] Northwestern Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA
关键词
cartilage; osteoarthritis; knee; POLYUNSATURATED FATTY-ACIDS; DIETARY WEIGHT-LOSS; OBESE OLDER-ADULTS; CHONDROITIN SULFATE; FISH-OIL; QUADRICEPS WEAKNESS; MEDITERRANEAN DIET; INTENSIVE DIET; JOINT LOADS; OSTEOARTHRITIS;
D O I
10.1055/s-0040-1713813
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The nonoperative practitioner managing individuals with cartilage defects should use a patient-centered, multifaceted approach that aims to individualize treatment to provide optimal benefit. These include addressing modifiable risk factors for disease progression and instituting interventions such as weight loss, nutrition, physical activity, and potentially regenerative medicine strategies. This review will focus on these nonoperative treatment strategies with a focus on when treatments are necessary, who will benefit from these approaches, why they are specifically appropriate, and, finally, how these treatments directly modify the structure of a patient's cartilage and resulting symptoms.
引用
收藏
页码:1078 / 1087
页数:10
相关论文
共 50 条
  • [31] Identification of Candidates for Progesterone Why, Who, How, and When?
    Iams, Jay D.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 (06): : 1317 - 1326
  • [32] PHYSICIANS WHO DISPENSE - WHY, WHEN AND HOW WELL
    HYDE, NA
    ROBERTS, RW
    PEVONKA, MP
    AMERICAN PHARMACY, 1978, 18 (13): : 18 - 21
  • [33] Evaluation of cartilage defects in the knee
    Spahn, G.
    Wittig, R.
    Kahl, E.
    Klinger, H. M.
    Mueckley, T.
    Hofmann, G. O.
    UNFALLCHIRURG, 2007, 110 (05): : 414 - 424
  • [34] Management of hyperlipidaemia - Why, when and how to treat
    Oliver, MF
    Pyorala, K
    Shepherd, J
    EUROPEAN HEART JOURNAL, 1997, 18 (03) : 371 - 375
  • [35] Open abdomen management: why, when and how?
    Dionigi, R.
    Rausei, S.
    Dionigi, G.
    Boni, L.
    GIORNALE DI CHIRURGIA, 2011, 32 (04): : 177 - 180
  • [36] Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why?
    Galsky, Matthew D.
    Domingo-Domenech, Josep
    Sfakianos, John P.
    Ferket, Bart S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (29) : 3495 - +
  • [37] Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why
    Guerrero Orriach, J. L.
    Ramirez-Fernandez, A.
    Escalona-Belmonte, J. J.
    Rubio-Navarro, M.
    Cruz-Manas, J.
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (04) : 310 - 318
  • [38] POLICE PUBLIC INFORMATION - WHO, WHAT, WHEN, WHY AND HOW
    PAGE, R
    POLICE CHIEF, 1970, 37 (10): : 28 - &
  • [39] Sex as a Biological Variable: Who, What, When, Why, and How
    Tracy L Bale
    C Neill Epperson
    Neuropsychopharmacology, 2017, 42 : 386 - 396
  • [40] Breast cancer screening controversies: who, when, why, and how?
    Chetlen, Alison
    Mack, Julie
    Chan, Tiffany
    CLINICAL IMAGING, 2016, 40 (02) : 279 - 282